Cargando…
Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma
Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents. Chemotherapy drugs play an integral role in OS treatment. Preoperative neoadjuvant chemotherapy and postoperative conventional adjuvant chemotherapy improve survival in patients with OS. However, the toxic side ef...
Autores principales: | Hou, Yulin, Wang, Jie, Wang, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579615/ https://www.ncbi.nlm.nih.gov/pubmed/37854721 http://dx.doi.org/10.3389/fphar.2023.1284406 |
Ejemplares similares
-
Engineered nanomaterials enhance drug delivery strategies for the treatment of osteosarcoma
por: Zhang, Haorui, et al.
Publicado: (2023) -
Current Therapeutic Strategies for Adipose Tissue Defects/Repair Using Engineered Biomaterials and Biomolecule Formulations
por: Mahoney, Christopher M., et al.
Publicado: (2018) -
Biomaterials for the Delivery of Growth Factors and Other Therapeutic Agents in Tissue Engineering Approaches to Bone Regeneration
por: Kowalczewski, Christine J., et al.
Publicado: (2018) -
Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity
por: Qin, Yeyu, et al.
Publicado: (2022) -
Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord
por: Ziemba, Alexis M., et al.
Publicado: (2017)